Dr. Crozier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2601 21st Ave S
Nashville, TN 37232Phone+1 615-322-4916
Education & Training
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2003 - 2007
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1997 - 2001
- Vanderbilt University School of MedicineClass of 1997
Certifications & Licensure
- TN State Medical License 2002 - 2012
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 29 citationsFirst-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.Ian Crozier, Haris M. Haqqani, E. Kotschet, David Shaw, Anil Prabhu
JACC. Clinical Electrophysiology. 2020-08-26 - 12 citationsComprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study.William J. Liu, F. R. Sesay, Antoine Coursier, Barbara Knust, Jaclyn E. Marrinan
Open Forum Infectious Diseases. 2019-02-26 - 40 citationsIdentification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell CulturesJulie Dyall, Elizabeth A. Nelson, Lisa Evans DeWald, Rajarshi Guha, Brit J. Hart
The Journal of Infectious Diseases. 2018-11-22
Journal Articles
- Ebola Virus Infection Associated with Transmission from SurvivorsBarbara J Marston, Ian Crozier, Centers for Disease Control and Prevention
Authored Content
- Ebola Virus Infection Associated with Transmission from SurvivorsNovember 2018
Press Mentions
- Extravascular ICD Safe, Able to Terminate Ventricular ArrhythmiasSeptember 6th, 2022
- Medtronic’s First-of-Its-Kind ICD Meets Safety Endpoints in Global Clinical TrialAugust 29th, 2022
- Medtronic Initiates Worldwide Pivotal Study of a New Approach to Treating Dangerously Fast Heart RhythmsOctober 11th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: